touchNEUROLOGY is pleased to present a panel discussion on “Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives” with expert faculty discussing recent advances in timely, biomarker-guided diagnosis, and considering how current and emerging intravenous (IV) and subcutaneous disease-modifying therapies may impact clinical practice and enable treatment individualisation based on the underlying pathology of Alzheimer’s disease.
This activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and touchIME in collaboration with the Gerontological Society of America (GSA).
Watch the panel discussion: https://touchneurologyime.org/subcutaneous-therapies-and-diagnostic-innovation-in-alzheimers/
